The present invention relates to substituted-cyanopyrrolidines of Formula (I) with activity as inhibitors of deubiquitilating enzymes, in particular, ubiquitin C-terminal hydrolase 30 or ubiquitin specific peptidase 30 (USP30), having utility in a variety of therapeutic areas including cancer and conditions involving mitochondrial dysfunction. (I)
本发明涉及一种具有抑制去泛素化酶活性的Formula(I)的替代
氰基
吡咯烷化合物,特别是泛素C-末端
水解酶30或泛素特异性肽酶30(U
SP30),在包括癌症和涉及线粒体功能障碍在内的各种治疗领域具有实用性。